{
    "2020-11-01": [
        [
            {
                "time": "",
                "original_text": "医药生物行业专题研究：从壁垒出发寻找医美领域的确定性机遇",
                "features": {
                    "keywords": [
                        "医药生物",
                        "专题研究",
                        "壁垒",
                        "医美",
                        "确定性",
                        "机遇"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物",
                        "医美"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "华熙生物(688363)：收入业绩增速提升 品牌元年值得期待",
                "features": {
                    "keywords": [
                        "华熙生物",
                        "688363",
                        "收入",
                        "业绩",
                        "增速",
                        "品牌",
                        "元年",
                        "期待"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}